Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBH vs PBE overlap: 40% of top holdings shared

Bottom line

How much do BBH and PBE overlap?

40% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 64.3% of BBH's assets and 47.9% of PBE's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

BBHPBE
Weight overlap (top 25)40%
Shared holdings12
Weight in shared holdings64.3%47.9%
Total positions2533
Expense ratio0.35%0.59%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings BBH and PBE have in common

Holding% of BBH% of PBEOverlap
Amgen Inc15.25%5.22%5.22%
Gilead Sciences Inc12.79%4.43%4.43%
Vertex Pharmaceuticals Inc9.10%4.99%4.99%
Regeneron Pharmaceuticals Inc6.21%5.47%5.47%
Alnylam Pharmaceuticals Inc3.83%3.17%3.17%
Biogen Inc3.63%4.79%3.63%
Illumina Inc3.17%3.51%3.17%
United Therapeutics Corp2.83%4.08%2.83%
Incyte Corp2.49%3.06%2.49%
Neurocrine Biosciences Inc2.08%2.66%2.08%
Bio-Techne Corp1.54%3.73%1.54%
BioMarin Pharmaceutical Inc1.34%2.82%1.34%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBH

  1. Revolution Medicines Inc — 5.27%
  2. Argenx SE — 4.97%
  3. Natera Inc — 4.92%
  4. IQVIA Holdings Inc — 4.31%
  5. Moderna Inc — 3.36%
  6. BeOne Medicines Ltd — 2.81%
  7. Insmed Inc — 2.67%
  8. BioNTech SE — 1.94%
  9. Icon Plc — 1.90%
  10. Charles River Laboratories International Inc — 1.50%
  11. Qiagen Nv — 1.06%
  12. Tempus AI Inc — 0.98%
  13. State Street Global Advisors — 0.06%

Only in PBE

  1. Invesco Private Prime Fund — 12.89%
  2. CareDx, Inc. — 5.04%
  3. Invesco Private Government Fund — 4.97%
  4. Royalty Pharma PLC — 4.94%
  5. Protagonist Therapeutics, Inc. — 3.40%
  6. Vericel Corp. — 3.27%
  7. Repligen Corp. — 3.04%
  8. Acadia Pharmaceuticals Inc. — 3.02%
  9. Halozyme Therapeutics, Inc. — 2.98%
  10. Qiagen N.V. — 2.89%
  11. Exelixis, Inc. — 2.64%
  12. BioCryst Pharmaceuticals, Inc. — 2.63%
  13. Veracyte, Inc. — 2.60%

Asset mix

Asset typeBBHPBE
Stocks100.0%100.1%
Cash & short-term funds0.1%17.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryBBHPBE
US87.3%108.6%
NL6.0%2.9%
GB—4.9%
CH2.8%—
DE1.9%—
IE1.9%—
KY—1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do BBH and PBE overlap?
About 40% by weight. 12 securities appear in both funds' top 25 holdings; they make up 64.3% of BBH's assets and 47.9% of PBE's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do BBH and PBE have in common?
The largest shared holdings are Regeneron Pharmaceuticals Inc, Amgen Inc, Vertex Pharmaceuticals Inc, Gilead Sciences Inc, Biogen Inc.
Should I own both BBH and PBE?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, BBH or PBE?
PBE is broader, with 33 positions versus 25 for BBH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.